Our previous research (Avtanski et al. 2019) and other studies (Dalamaga 2014; Dasgupta and Klein 2014; Wang et al. 2018) have demonstrated that resistin induces EMT, thereby promoting breast cancer metastasis and progression. Here, RETN is linked to breast cancer.